Gastric carcinoids: Does type of surgery or tumor affect survival?

被引:9
|
作者
Crown, Angelena [1 ]
Kennecke, Hagen [1 ]
Kozarek, Richard [1 ]
Lopez-Aguiar, Alexandra G. [2 ]
Dillhoff, Mary [3 ]
Beal, Eliza W. [3 ]
Poultsides, George A. [4 ]
Makris, Eleftherios [4 ]
Idrees, Kamran [5 ]
Smith, Paula Marincola [5 ]
Nathan, Hari [6 ]
Beems, Megan [6 ]
Abbott, Daniel [7 ]
Fisher, Alexander, V [7 ]
Fields, Ryan C. [8 ]
Davidson, Jesse [8 ]
Maithel, Shishir K. [2 ]
Rocha, Flavio G. [1 ]
机构
[1] Virginia Mason Med Ctr, Digest Dis Inst, Seattle, WA 98101 USA
[2] Emory Univ, Div Surg Oncol, Dept Surg, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Div Surg Oncol, Columbus, OH 43210 USA
[4] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[5] Vanderbilt Univ, Dept Surg, Med Ctr, Div Surg Oncol, Nashville, TN 37240 USA
[6] Univ Michigan, Dept Surg, Div Hepatopancreatobiliary & Adv Gastrointestinal, Ann Arbor, MI 48109 USA
[7] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
[8] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
来源
AMERICAN JOURNAL OF SURGERY | 2019年 / 217卷 / 05期
关键词
ZOLLINGER-ELLISON-SYNDROME; MANAGEMENT;
D O I
10.1016/j.amjsurg.2018.12.057
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Gastric carcinoids are rare neuroendocrine tumors of the gastrointestinal tract. They are typically managed according to their etiology. However, there is little known about the impact of surgical strategy on the long-term outcomes of these patients. Methods: All patients who underwent resection of gastric carcinoids at 8 institutions from 2000 to 2016 were analyzed retrospectively. Tumors were stratified according to subtype (I, II, III, IV) and resection type (local resection, LR or formal gastrectomy, FG). Clinicopathological parameters, recurrence-free (RFS) and overall survival (OS) were compared between groups. Results: Of 79 patients identified with gastric carcinoids, 34 had type I lesions associated with atrophic gastritis, 4 had type II lesions associated with a gastrinoma, 37 had type III sporadic lesions, and 4 had type IV poorly-differentiated lesions. The mean age of presentation was 56 years in predominantly Caucasian (77%) and female (63%) patients. Mean tumor size was 2.4 cm and multifocal tumors were found in 24 (30%) of patients with the majority occurring in those with type I tumors. Lymph node positive tumors were seen in 15 (19%) patients and 7 (8%) had M1 disease; both most often in type IV followed by type III tumors. R0 resection was achieved in 56 (71%) patients while 15 (19%) had R1 resections and 6 (8%) R2 resections. Patients with type I and III tumors were equally likely to have a LR (50% and 43% respectively) compared to FG while those with type II and IV all had FG with one exception. Type IV tumors had the poorest RFS and OS while Type II tumors had the most favorable RFS and OS (p < 0.04 and p < 0.0004, respectively). While there was no difference in RFS in those patients undergoing FG versus LR, OS was worse in the FG group (p < 0.017). This trend persisted when type II and type IV groups were excluded (p < 0.045). Conclusion: Gastric carcinoid treatment should be tailored to tumor type, as biologic behavior rather than resection technique is the more important factor contributing to long-term outcomes. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 50 条
  • [1] Gastric carcinoids: Does type of surgery or tumor affect survival?
    Crown, Angelena
    Kanji, Zaheer S.
    Lopez-Aguiar, Alexandra G.
    Dillhoff, Mary
    Poultsides, George A.
    Makris, Eleftherios
    Idrees, Kamran
    Smith, Paula Marincola
    Nathan, Hari
    Beems, Megan
    Weber, Sharon M.
    Fisher, Alexander V.
    Fields, Ryan
    Davidson, Jesse
    Maithel, Shishir
    Rocha, Flavio G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Gastric Carcinoids: Does Type of Surgery or Tumor Affect Survival?
    Crown, A.
    Kanji, Z. S.
    Lopez-Aguiar, A. G.
    Dillhoff, M.
    Beal, E. W.
    Poultsides, G.
    Makris, E. A.
    Idrees, K.
    Smith, P. Marincola
    Nathan, H.
    Beems, M.
    Weber, S.
    Fisher, A.
    Fields, R.
    Davidson, J.
    Maithel, S. K.
    Rocha, F. G.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S200 - S200
  • [3] DOES PRIMARY TUMOR RESECTION AFFECT SURVIVAL IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER?
    Yalcin Musri, Fatma
    Mutlu, Hasan
    Karaagac, Mustafa
    Gunduz, Seyda
    Karakurt Eryilmaz, Melek
    Kivrak Salim, Derya
    Tazegul, Gokhan
    Musri, Ozgur Cem
    Goksu, Sema Sezgin
    Coskun, Hasan Senol
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2016, 19 (03): : 169 - 173
  • [4] Gastric Carcinoids Tumors and Bariatric Surgery
    Molina, H.
    Pacheco, F.
    Alvarez, R.
    Ortiz, V.
    Alarcon, A.
    OBESITY SURGERY, 2011, 21 (08) : 1135 - 1135
  • [5] Gastric Carcinoids Tumors and Bariatric Surgery
    Pacheco Bastidas, F.
    Molina Zapata, H.
    Alvarez Uslar, R.
    Farias Marambio, R.
    OBESITY SURGERY, 2009, 19 (08) : 1043 - 1043
  • [6] Histopathological grading does not affect survival after R0 surgery for gastric cancer
    Inoue, K
    Nakane, Y
    Michiura, T
    Nakai, K
    Iiyama, H
    Sato, M
    Okumura, S
    Yamamichi, K
    Hioki, K
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (06): : 633 - 636
  • [7] Breast Cancer: Does Type of Hospital Where You Get Surgery Affect Survival?
    Lin, Jenny J.
    Egorova, Natalia
    Franco, Rebeca
    Bickell, Nina A.
    JOURNAL FOR HEALTHCARE QUALITY, 2019, 41 (01) : 49 - 58
  • [8] Does the type of conduit affect allograft survival?
    Seetahal, V.
    Bissoon, D.
    BJU INTERNATIONAL, 2016, 117 : 4 - 4
  • [10] DOES PARITY AFFECT TYPE OF PROLAPSE SURGERY?
    Troko, J.
    Cooper, J.
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 : S318 - S319